Pharmacodynamics, pharmacokinetics, and safety of single-dose subcutaneous administration of selatogrel, a novel P2Y12 receptor antagonist, in patients with chronic coronary syndromes - Storey, R F; Gurbel, P A; Ten Berg, J (Eur Heart J, 2020)